[HTML][HTML] Clinical and Genomic Evolution of Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections over Two Time Periods at a Tertiary Care Hospital …

A Manesh, C Shankar, MM George, DS Jasrotia… - Infectious Diseases and …, 2023 - Springer
Introduction The objective of this study was to examine the evolution of carbapenem-
resistant Klebsiella pneumoniae (CRKp) infections and their impact at a tertiary care hospital …

Clinical and genomic evolution of carbapenem-resistant Klebsiella pneumoniae bloodstream infections over two time periods at a tertiary care hospital in South India …

A Manesh, C Shankar, MM George, DS Jasrotia, B Lal… - 2023 - cabidigitallibrary.org
Introduction: The objective of this study was to examine the evolution of carbapenem-
resistant Klebsiella pneumoniae (CRKp) infections and their impact at a tertiary care hospital …

Clinical and genomic evolution of carbapenem-resistant klebsiella pneumoniae bloodstream infections over two time periods at a tertiary care hospital in South India …

A Manesh, C Shankar, MM George… - Infectious …, 2023 - discovery.dundee.ac.uk
Introduction: The objective of this study was to examine the evolution of carbapenem-
resistant Klebsiella pneumoniae (CRKp) infections and their impact at a tertiary care hospital …

Clinical and Genomic Evolution of Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections over Two Time Periods at a Tertiary Care Hospital in South …

A Manesh, C Shankar, MM George… - Infectious diseases …, 2023 - pubmed.ncbi.nlm.nih.gov
Introduction The objective of this study was to examine the evolution of carbapenem-
resistant Klebsiella pneumoniae (CRKp) infections and their impact at a tertiary care hospital …

[PDF][PDF] Clinical and Genomic Evolution of Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections over Two Time Periods at a Tertiary Care Hospital in …

BVGM Varghese - 2023 - academia.edu
Introduction: The objective of this study was to examine the evolution of carbapenem-
resistant Klebsiella pneumoniae (CRKp) infections and their impact at a tertiary care hospital …

Clinical and Genomic Evolution of Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections over Two Time Periods at a Tertiary Care Hospital in South …

A Manesh, C Shankar, MM George… - … Diseases and Therapy, 2023 - go.gale.com
Introduction The objective of this study was to examine the evolution of carbapenem-
resistant Klebsiella pneumoniae (CRKp) infections and their impact at a tertiary care hospital …

Clinical and Genomic Evolution of Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections over Two Time Periods at a Tertiary Care Hospital in South …

A Manesh, C Shankar, MM George… - Infectious Diseases …, 2023 - search.proquest.com
Methods A comparative analysis of clinical data from two prospective cohorts of patients with
CRKp bacteremia (C1, 2014–2015; C2, 2021–2022) was carried out. Antimicrobial …

Clinical and Genomic Evolution of Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections over Two Time Periods at a Tertiary Care Hospital in South …

A Manesh, C Shankar, MM George… - Infectious Diseases …, 2023 - squ.elsevierpure.com
Introduction: The objective of this study was to examine the evolution of carbapenem-
resistant Klebsiella pneumoniae (CRKp) infections and their impact at a tertiary care hospital …

Clinical and Genomic Evolution of Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections over Two Time Periods at a Tertiary Care Hospital in South …

A Manesh, C Shankar, MM George… - Infectious Diseases …, 2023 - europepmc.org
Methods A comparative analysis of clinical data from two prospective cohorts of patients with
CRKp bacteremia (C1, 2014-2015; C2, 2021-2022) was carried out. Antimicrobial …

[HTML][HTML] Clinical and Genomic Evolution of Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections over Two Time Periods at a Tertiary Care Hospital …

A Manesh, C Shankar, MM George… - Infectious Diseases …, 2023 - ncbi.nlm.nih.gov
Methods A comparative analysis of clinical data from two prospective cohorts of patients with
CRKp bacteremia (C1, 2014–2015; C2, 2021–2022) was carried out. Antimicrobial …